IGF-1 facilitates thrombopoiesis primarily through Akt activation

Area of Science:

• Hematology
• Cell Biology
• Molecular Biology

Background:

• Insulin-like growth factor-1 (IGF-1) is recognized as a hematopoietic factor.
• Its specific role in thrombopoiesis, the process of platelet generation, requires further elucidation.

Purpose of the Study:

• To investigate the direct effects of IGF-1 on thrombopoiesis.
• To elucidate the molecular mechanisms underlying IGF-1-mediated platelet production.

Main Methods:

• In vitro culture of CD34+ cells to megakaryocytes (MKs) and assessment of proplatelet formation (PPF).
• In vivo studies involving irradiated mice and bone marrow transplantation models.
• Analysis of signaling pathways including extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt.
• Experiments utilizing homozygous TPO receptor mutant mice.

Main Results:

• IGF-1 promotes CD34+ cell differentiation into MKs, enhances PPF, and increases platelet production in vitro.
• IGF-1 accelerates platelet recovery in mice post-irradiation and bone marrow transplantation.
• Both ERK1/2 and Akt pathways mediate IGF-1's thrombopoietic effects, with Akt activation being more pronounced.
• IGF-1 stimulates platelet production independently of TPO signaling, as evidenced in TPO receptor mutant mice.
• Akt activation by IGF-1 requires steroid receptor coactivator-3 (SRC-3).

Conclusions:

• IGF-1 plays a distinct role in regulating thrombopoiesis.
• IGF-1 promotes platelet generation through TPO-independent pathways involving Akt and ERK1/2 signaling.
• The findings offer new insights into the regulation of platelet production.